Skip to main content
NIH funding notice RFA-CA-17-013

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)

Closed on September 26, 2017.

Posted
November 7, 2016
Close date
September 26, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$373,591
$747,181 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
  2. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE1

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 TCRB-Q (O1))1
  2. Special Emphasis Panel (ZCA1 TCRB-W (M2))1
2 awards under RFA-CA-17-013 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2018Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers1R33CA214310-01A1Ince, Tan A.UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FLFirst-year cost $382,215Study section ZCA1
FY2018Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity1R33CA217702-01A1Borges, Chad RARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZFirst-year cost $364,966Study section ZCA1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.